O'Shaughnessy Ventures Awards Fellowship for Development of Injectable Blood Vessel Therapy

O'Shaughnessy Ventures has awarded a fellowship to Liam Aranda-Michel, an MIT bioengineering researcher working on injectable vascular units that could restore blood flow without surgery. The therapy aims to provide a more accessible and effective treatment option for patients with circulation-related conditions.

By O'Shaughnessy Ventures · PR Newswire ·

O'Shaughnessy Ventures Awards Fellowship for Development of Injectable Blood Vessel Therapy

Topics: bioengineering fellowship vascular therapy

Read the full article at PR Newswire

More World news